PC
AVNS

Permanens Capital’s Avanos Medical AVNS Stock Holding History

Permanens Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6
Closed – – 116
2020
Q1 		$0 Buy
+6
New +$179 ﹤0.01% 113
2019
Q4 		– Sell
-6
Closed – – 132
2019
Q3 		$0 Hold
6
– – ﹤0.01% 104
2019
Q2 		$0 Hold
6
– – ﹤0.01% 106
2019
Q1 		$0 Buy
+6
New +$269 ﹤0.01% 91

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Permanens Capital's AVNS Position: Q2 2020 in Review

Permanens Capital sold out of Avanos Medical (AVNS) in Q2 2020, closing a stake of 6 shares.

Permanens Capital first reported a position in AVNS in Q1 2019 and held it in 4 quarters. The position peaked at $0 in Q1 2020. 277 funds tracked by Wall St. Rank hold AVNS as of Q2 2020.

  • Permanens Capital reported no remaining Avanos Medical position as of Q2 2020 after selling out during the quarter.
  • Permanens Capital sold 6 Avanos Medical shares in Q2 2020.
  • Permanens Capital first reported a position in Avanos Medical in Q1 2019 and held it in 4 quarters.
  • Permanens Capital's Avanos Medical position peaked at $0 in Q1 2020.
  • 277 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2020.

Based on Permanens Capital's 13F filing for Q2 2020, filed 13 Aug 2020.